BioWorld

June 15, 2009

View Archived Issues

Economics, Exits Forcing Return of One-Trick Pony

A few years ago, you couldn't make it through a biotech investor presentation without hearing about "multiple shots on goal." But with cash in short supply and exit strategies limited, "tightly-focused" is the new catchphrase of the day. Read More

Money Raised Year to Date

Read More

Changed XOMA Wager Uses Kineret's Route - To Diabetes

Read More

BioMarin Not Minding the Gap; License Deal All in Good Time

Read More

Money Raised in 2009

Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Phase I Clinical Trials Update: May 2009

Read More

Phase II Clinical Trials Update: May 2009

Read More

Pivotal/Phase III Clinical Trials Update: May 2009

Read More

American Society of Clinical Oncology

Read More

Non-U.S. Clinical Trials And Regulatory Actions: May 2009

Read More

FDA Submissions, Approvals And Other Actions: May 2009

Read More

Stock Winners and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More